{"transactions":[{"id":1104548,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":78258,"kind":"person","name":"KNOBELMAN DEBORAH","position":1,"cik":"0001931509","reported_name":"KNOBELMAN DEBORAH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Interim CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-06-20T16:15:13.000Z","date":"2025-06-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":246390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of immediately prior to and conditioned upon the effective time of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an \"Option\") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (a) an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the excess, if any, of the Cash Amount over the exercise price per share of each such Option and (2) the number of Shares underlying such Option immediately prior to the effective time of the Merger and (b) one CVR in respect of each Share underlying such Option; provided, however, that if the exercise price per Share of any Option was equal to or greater than the Cash Amount that was then outstanding it was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":0.745,"expiration_date":"2034-06-02","underlying":"Common Stock","underlying_shares":246390},"source":{"system":"sec-edgar","filing":"0001415889-25-017823","document":"form4-06202025_040601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741830/000141588925017823/form4-06202025_040601.xml","form_type":"4"}},{"id":1104547,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":78258,"kind":"person","name":"KNOBELMAN DEBORAH","position":1,"cik":"0001931509","reported_name":"KNOBELMAN DEBORAH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Interim CEO"}}],"security":"Common Stock","published_at":"2025-06-20T16:15:13.000Z","date":"2025-06-20","kind":"other","planned":false,"acquired":false,"shares":139422,"price":0.57,"value":79470.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of May 1, 2025, by and among Kronos Bio, Inc. (the \"Issuer\"), Concentra Biosciences, LLC (\"Parent\") and Concentra Merger Sub IV, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"). On June 18, 2025, Parent and Merger Sub completed a tender offer pursuant to the terms of the Merger Agreement for all outstanding shares of common stock of the Issuer (each, a \"Share\") for an offer price of (i) $0.57 per Share in cash (the \"Cash Amount\"), and (ii) one non-transferable contractual contingent value right (each, a \"CVR\"), subject to and in accordance with the terms of the Contingent Value Rights Agreement (the \"CVR Agreement\"), in each case, without interest, and subject to any applicable withholding taxes (the Cash Amount plus one CVR, collectively, the \"Offer Price\").[continues to Footnote 2]"},{"field":"shares","element":"transactionShares","label":"F2","text":"[continues from Footnote 1] Merger Sub thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the \"Merger\"). At the effective time of the Merger, each issued and outstanding Share (other than any Excluded Shares (as such term is defined in the Merger Agreement)) was cancelled in exchange for the right to receive the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-25-017823","document":"form4-06202025_040601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741830/000141588925017823/form4-06202025_040601.xml","form_type":"4"}},{"id":1119109,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":78258,"kind":"person","name":"KNOBELMAN DEBORAH","position":1,"cik":"0001931509","reported_name":"KNOBELMAN DEBORAH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & Interim CEO"}}],"security":"Common Stock","published_at":"2025-06-06T16:47:48.000Z","date":"2025-06-05","kind":"sale","planned":false,"acquired":false,"shares":24838,"price":0.8678,"value":21554.4164,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy estimated tax withholding obligations upon the settlement of restricted stock units."}],"balance_after":139422,"source":{"system":"sec-edgar","filing":"0001415889-25-016003","document":"form4-06062025_080640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741830/000141588925016003/form4-06062025_080640.xml","form_type":"4"}},{"id":1491309,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":78258,"kind":"person","name":"KNOBELMAN DEBORAH","position":1,"cik":"0001931509","reported_name":"KNOBELMAN DEBORAH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-06-04T17:02:06.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":246390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares shall vest and become exercisable on June 3, 2025 and the remaining shares shall vest in 36 equal monthly installments as of the last calendar day of each month thereafter."}],"balance_after":246390,"derivative":{"exercise_price":0.745,"expiration_date":"2034-06-02","underlying":"Common Stock","underlying_shares":246390},"source":{"system":"sec-edgar","filing":"0001415889-24-015398","document":"form4-06042024_090603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741830/000141588924015398/form4-06042024_090603.xml","form_type":"4"}},{"id":1491308,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":78258,"kind":"person","name":"KNOBELMAN DEBORAH","position":1,"cik":"0001931509","reported_name":"KNOBELMAN DEBORAH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-04T17:02:06.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":164260,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":164260,"source":{"system":"sec-edgar","filing":"0001415889-24-015398","document":"form4-06042024_090603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741830/000141588924015398/form4-06042024_090603.xml","form_type":"4"}},{"id":1662066,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":78258,"kind":"person","name":"KNOBELMAN DEBORAH","position":1,"cik":"0001931509","reported_name":"KNOBELMAN DEBORAH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"Chief Financial Officer","other_text":"Head of Corporate Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-02T22:24:38.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":152000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest in 48 substantially equal monthly installments over four years from February 1, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":152000,"derivative":{"exercise_price":0.46,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":152000},"source":{"system":"sec-edgar","filing":"0001854270-24-000013","document":"wk-form4_1706912660.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427024000013/wk-form4_1706912660.xml","form_type":"4"}},{"id":1662065,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":78258,"kind":"person","name":"KNOBELMAN DEBORAH","position":1,"cik":"0001931509","reported_name":"KNOBELMAN DEBORAH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"Chief Financial Officer","other_text":"Head of Corporate Development"}}],"security":"Common Stock","published_at":"2024-02-02T22:24:38.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":101000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent restricted stock units (\"RSUs\") issued under the Senti Biosciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. All of the shares underlying the award vest in three substantially equal annual installments over three years from February 1, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":131000,"source":{"system":"sec-edgar","filing":"0001854270-24-000013","document":"wk-form4_1706912660.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427024000013/wk-form4_1706912660.xml","form_type":"4"}},{"id":2036480,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":78258,"kind":"person","name":"KNOBELMAN DEBORAH","position":1,"cik":"0001931509","reported_name":"KNOBELMAN DEBORAH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-02T22:20:57.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in 48 substantially equal monthly installments over four years from February 1, 2023, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":130000,"derivative":{"exercise_price":1.81,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001854270-23-000019","document":"wf-form4_167537644193252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427023000019/wf-form4_167537644193252.xml","form_type":"4"}},{"id":2144994,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":78258,"kind":"person","name":"KNOBELMAN DEBORAH","position":1,"cik":"0001931509","reported_name":"KNOBELMAN DEBORAH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-04T20:47:13.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this option vest on September 20, 2023 and the remainder vest in 36 substantially equal monthly installments thereafter, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":240000,"derivative":{"exercise_price":2.5,"expiration_date":"2032-10-02","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001854270-22-000036","document":"wf-form4_166491640953549.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427022000036/wf-form4_166491640953549.xml","form_type":"4"}},{"id":2144993,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":78258,"kind":"person","name":"KNOBELMAN DEBORAH","position":1,"cik":"0001931509","reported_name":"KNOBELMAN DEBORAH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-10-04T20:47:13.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent restricted stock units (\"RSUs\") issued under the Senti Biosciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. All of the shares underlying the award will vest on September 20, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001854270-22-000036","document":"wf-form4_166491640953549.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427022000036/wf-form4_166491640953549.xml","form_type":"4"}}]}